ID   HGS_RAT                 Reviewed;         776 AA.
AC   Q9JJ50; P97847; Q5XIV8; Q76N76;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   24-JUL-2024, entry version 164.
DE   RecName: Full=Hepatocyte growth factor-regulated tyrosine kinase substrate;
DE   AltName: Full=SNAP-25-interacting protein Hrs-2;
GN   Name=Hgs; Synonyms=Hrs, Hrs2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND INTERACTION
RP   WITH SNAP25.
RX   PubMed=9039916; DOI=10.1038/385826a0;
RA   Bean A.J., Seifert R., Chen Y.A., Sacks R., Scheller R.H.;
RT   "Hrs-2 is an ATPase implicated in calcium-regulated secretion.";
RL   Nature 385:826-829(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=9798906; DOI=10.1046/j.1471-4159.1998.71051827.x;
RA   Ogura K., Kohno K., Tai T.;
RT   "Molecular cloning of a rat brain cDNA, with homology to a tyrosine kinase
RT   substrate, that induces galactosylceramide expression in COS-7 cells.";
RL   J. Neurochem. 71:1827-1836(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, DOMAIN, AND INTERACTION WITH SNAP25.
RX   PubMed=10825299; DOI=10.1242/jcs.113.12.2273;
RA   Kwong J., Roudabush F.L., Moore P.H., Montague M., Oldham W., Li Y.,
RA   Chin L.-S., Li L.;
RT   "Hrs interacts with SNAP-25 and regulates Ca2+-dependent exocytosis.";
RL   J. Cell Sci. 113:2273-2284(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH EPS15.
RX   PubMed=10809762; DOI=10.1074/jbc.275.20.15271;
RA   Bean A.J., Davanger S., Chou M.F., Gerhardt B., Tsujimoto S., Chang Y.;
RT   "Hrs-2 regulates receptor-mediated endocytosis via interactions with
RT   Eps15.";
RL   J. Biol. Chem. 275:15271-15278(2000).
RN   [6]
RP   INTERACTION WITH SNX1, AND DOMAIN.
RX   PubMed=11110793; DOI=10.1074/jbc.m004129200;
RA   Chin L.-S., Raynor M.C., Wei X., Chen H.-Q., Li L.;
RT   "Hrs interacts with sorting nexin 1 and regulates degradation of epidermal
RT   growth factor receptor.";
RL   J. Biol. Chem. 276:7069-7078(2001).
RN   [7]
RP   INTERACTION WITH TRAK2.
RX   PubMed=17062640; DOI=10.1242/jcs.03249;
RA   Kirk E., Chin L.S., Li L.;
RT   "GRIF1 binds Hrs and is a new regulator of endosomal trafficking.";
RL   J. Cell Sci. 119:4689-4701(2006).
CC   -!- FUNCTION: Involved in intracellular signal transduction mediated by
CC       cytokines and growth factors. When associated with STAM, it suppresses
CC       DNA signaling upon stimulation by IL-2 and GM-CSF. Could be a direct
CC       effector of PI3-kinase in vesicular pathway via early endosomes and may
CC       regulate trafficking to early and late endosomes by recruiting
CC       clathrin. May concentrate ubiquitinated receptors within clathrin-
CC       coated regions. Involved in down-regulation of receptor tyrosine kinase
CC       via multivesicular body (MVBs) when complexed with STAM (ESCRT-0
CC       complex). The ESCRT-0 complex binds ubiquitin and acts as a sorting
CC       machinery that recognizes ubiquitinated receptors and transfers them to
CC       further sequential lysosomal sorting/trafficking processes. Involved in
CC       receptor recycling via its association with the CART complex, a
CC       multiprotein complex required for efficient transferrin receptor
CC       recycling but not for EGFR degradation (By similarity). May contribute
CC       to the efficient recruitment of SMADs to the activin receptor complex.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Component of the ESCRT-0 complex composed of STAM or STAM2 and
CC       HGS. Part of a complex at least composed of HSG, STAM2 (or probably
CC       STAM) and EPS15 (By similarity). Interacts with STAM (By similarity).
CC       Interacts with STAM2 (By similarity). Interacts with EPS15; the
CC       interaction is direct, calcium-dependent and inhibited by SNAP25
CC       (PubMed:10809762). Identified in a complex with STAM and LITAF (By
CC       similarity). Found in a complex with STAM and E3 ligase ITCH and DTX3L
CC       (By similarity). Interacts with E3 ligase DTX3L; the interaction brings
CC       together STAM and HSG, promotes their recruitment to early endosomes
CC       and decreases STAM and HGS ubiquitination by ITCH (By similarity).
CC       Interacts with NF2; the interaction is direct (By similarity).
CC       Interacts with ubiquitin; the interaction is direct (By similarity).
CC       Interacts with VPS37C (By similarity). Interacts with SMAD1, SMAD2 and
CC       SMAD3 (By similarity). Interacts with TSG101; the interaction mediates
CC       the association with the ESCRT-I complex (By similarity). Interacts
CC       with SNAP25; the interaction is direct and decreases with addition of
CC       increasing concentrations of free calcium (PubMed:10825299,
CC       PubMed:9039916). Interacts with SNX1; the interaction is direct
CC       (PubMed:11110793). Component of a 550 kDa membrane complex at least
CC       composed of HGS and SNX1 but excluding EGFR (PubMed:11110793).
CC       Interacts with TRAK2 (PubMed:17062640). Interacts with TRAK1 (By
CC       similarity). Component of the CART complex, at least composed of ACTN4,
CC       HGS/HRS, MYO5B and TRIM3 (By similarity). Interacts (via UIM domain)
CC       with UBQLN1 (via ubiquitin-like domain) (By similarity). Interacts with
CC       ARRDC3 (By similarity). Identified in a complex containing at least
CC       ARRDC4, AVPR2 and HGS (By similarity). Interacts with LAPTM4B; promotes
CC       HGS ubiquitination (By similarity). {ECO:0000250|UniProtKB:O14964,
CC       ECO:0000250|UniProtKB:Q99LI8, ECO:0000269|PubMed:10809762,
CC       ECO:0000269|PubMed:10825299, ECO:0000269|PubMed:11110793,
CC       ECO:0000269|PubMed:17062640, ECO:0000269|PubMed:9039916}.
CC   -!- INTERACTION:
CC       Q9JJ50; P54256: Hap1; NbExp=5; IntAct=EBI-7092491, EBI-994539;
CC       Q9JJ50; P54256-2: Hap1; NbExp=5; IntAct=EBI-7092491, EBI-994554;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10825299}. Early
CC       endosome membrane {ECO:0000269|PubMed:10825299}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:10825299}; Cytoplasmic side
CC       {ECO:0000269|PubMed:10825299}. Endosome, multivesicular body membrane
CC       {ECO:0000269|PubMed:10825299}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10825299}. Note=Colocalizes with UBQLN1 in
CC       ubiquitin-rich cytoplasmic aggregates that are not endocytic
CC       compartments. {ECO:0000250|UniProtKB:O14964}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9JJ50-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9JJ50-2; Sequence=VSP_014852;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:10825299, ECO:0000269|PubMed:9039916,
CC       ECO:0000269|PubMed:9798906}.
CC   -!- DOMAIN: Has a double-sided UIM that can bind 2 ubiquitin molecules, one
CC       on each side of the helix. {ECO:0000250}.
CC   -!- DOMAIN: The FYVE-type zinc finger domain mediates interactions with
CC       phosphatidylinositol 3-phosphate in membranes of early endosomes and
CC       penetrates bilayers. The FYVE domain insertion into PtdIns(3)P-enriched
CC       membranes is substantially increased in acidic conditions (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on Tyr-334. This phosphorylation occurs in response
CC       to EGF. A minor site of phosphorylation on Tyr-329 is detected. Protein
CC       phosphorylation may also be triggered in response to IL-2, GM-CSF and
CC       HGF (By similarity). {ECO:0000250|UniProtKB:Q99LI8}.
CC   -!- PTM: Ubiquitinated by ITCH. {ECO:0000250|UniProtKB:O14964}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB49681.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U87863; AAB49681.1; ALT_FRAME; mRNA.
DR   EMBL; AB002811; BAD08342.1; -; mRNA.
DR   EMBL; AF036344; AAF76251.1; -; mRNA.
DR   EMBL; BC083561; AAH83561.1; -; mRNA.
DR   RefSeq; NP_062260.2; NM_019387.2. [Q9JJ50-2]
DR   AlphaFoldDB; Q9JJ50; -.
DR   SMR; Q9JJ50; -.
DR   BioGRID; 248562; 7.
DR   CORUM; Q9JJ50; -.
DR   IntAct; Q9JJ50; 1.
DR   MINT; Q9JJ50; -.
DR   STRING; 10116.ENSRNOP00000051849; -.
DR   CarbonylDB; Q9JJ50; -.
DR   iPTMnet; Q9JJ50; -.
DR   PhosphoSitePlus; Q9JJ50; -.
DR   jPOST; Q9JJ50; -.
DR   PaxDb; 10116-ENSRNOP00000051849; -.
DR   GeneID; 56084; -.
DR   KEGG; rno:56084; -.
DR   AGR; RGD:69225; -.
DR   CTD; 9146; -.
DR   RGD; 69225; Hgs.
DR   eggNOG; KOG1818; Eukaryota.
DR   HOGENOM; CLU_013062_1_0_1; -.
DR   InParanoid; Q9JJ50; -.
DR   OrthoDB; 922060at2759; -.
DR   PhylomeDB; Q9JJ50; -.
DR   Reactome; R-RNO-182971; EGFR downregulation.
DR   Reactome; R-RNO-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-6807004; Negative regulation of MET activity.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-9013420; RHOU GTPase cycle.
DR   Reactome; R-RNO-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; R-RNO-9706019; RHOBTB3 ATPase cycle.
DR   PRO; PR:Q9JJ50; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0033565; C:ESCRT-0 complex; ISO:RGD.
DR   GO; GO:0032585; C:multivesicular body membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; ISO:RGD.
DR   GO; GO:0140036; F:ubiquitin-modified protein reader activity; ISO:RGD.
DR   GO; GO:0032456; P:endocytic recycling; IBA:GO_Central.
DR   GO; GO:0008333; P:endosome to lysosome transport; IMP:RGD.
DR   GO; GO:0010324; P:membrane invagination; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0046426; P:negative regulation of receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0072657; P:protein localization to membrane; ISO:RGD.
DR   GO; GO:0006622; P:protein targeting to lysosome; ISO:RGD.
DR   GO; GO:0031623; P:receptor internalization; IBA:GO_Central.
DR   CDD; cd15720; FYVE_Hrs; 1.
DR   CDD; cd21387; GAT_Hrs; 1.
DR   CDD; cd03569; VHS_Hrs; 1.
DR   Gene3D; 1.20.5.1940; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR017073; HGS/VPS27.
DR   InterPro; IPR024641; HRS_helical.
DR   InterPro; IPR003903; UIM_dom.
DR   InterPro; IPR002014; VHS_dom.
DR   InterPro; IPR000306; Znf_FYVE.
DR   InterPro; IPR017455; Znf_FYVE-rel.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR46275; HEPATOCYTE GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; 1.
DR   PANTHER; PTHR46275:SF1; HEPATOCYTE GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; 1.
DR   Pfam; PF01363; FYVE; 1.
DR   Pfam; PF12210; Hrs_helical; 1.
DR   Pfam; PF00790; VHS; 1.
DR   PIRSF; PIRSF036956; Hrs_Vps27; 1.
DR   SMART; SM00064; FYVE; 1.
DR   SMART; SM00288; VHS; 1.
DR   SUPFAM; SSF48464; ENTH/VHS domain; 1.
DR   SUPFAM; SSF57903; FYVE/PHD zinc finger; 1.
DR   PROSITE; PS50330; UIM; 1.
DR   PROSITE; PS50179; VHS; 1.
DR   PROSITE; PS50178; ZF_FYVE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Endosome; Membrane;
KW   Metal-binding; Phosphoprotein; Protein transport; Reference proteome;
KW   Transport; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..776
FT                   /note="Hepatocyte growth factor-regulated tyrosine kinase
FT                   substrate"
FT                   /id="PRO_0000098710"
FT   DOMAIN          15..143
FT                   /note="VHS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00218"
FT   DOMAIN          258..277
FT                   /note="UIM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   ZN_FING         160..220
FT                   /note="FYVE-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   REGION          223..319
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          225..542
FT                   /note="Interaction with SNX1"
FT                   /evidence="ECO:0000269|PubMed:11110793"
FT   REGION          338..401
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          444..542
FT                   /note="Interaction with SNAP25 and TRAK2"
FT                   /evidence="ECO:0000269|PubMed:17062640"
FT   REGION          453..571
FT                   /note="Interaction with STAM"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LI8"
FT   REGION          479..776
FT                   /note="Interaction with NF2"
FT                   /evidence="ECO:0000250"
FT   REGION          719..776
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        233..252
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        272..286
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        375..397
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        719..745
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        746..764
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         166
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         169
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         182
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         185
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         190
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         193
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         212
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         215
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   MOD_RES         207
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O14964"
FT   MOD_RES         216
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O14964"
FT   MOD_RES         308
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LI8"
FT   MOD_RES         329
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LI8"
FT   MOD_RES         334
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LI8"
FT   MOD_RES         550
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99LI8"
FT   VAR_SEQ         671..675
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9798906"
FT                   /id="VSP_014852"
FT   CONFLICT        394
FT                   /note="Missing (in Ref. 1; AAB49681)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        398
FT                   /note="G -> A (in Ref. 4; AAH83561)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        561
FT                   /note="A -> V (in Ref. 4; AAH83561)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   776 AA;  86246 MW;  FD61BEC121F37E67 CRC64;
     MGRGSGTFER LLDKATSQLL LETDWESILQ ICDLIRQGDT QAKYAVNSIK KKVNDKNPHV
     ALYALEVMES VVKNCGQTVH DEVANKQTME ELKELLKRQV EVNVRNKILY LIQAWAHAFR
     NEPKYKVVQD TYQIMKVEGH VFPEFKESDA MFAAERAPDW VDAEECHRCR VQFGVVTRKH
     HCRACGQIFC GKCSSKYSTI PKFGIEKEVR VCEPCYEQLN KKAEGKAAST TELPPEYLTS
     PLSQQSQLPP KRDETALQEE EELQLALALS QSEAEEKERM RQKSTYTAHP KSEPAPLASS
     APPAGSLYSS PVNSSAPLAE DIDPELARYL NRNYWEKKQE EARKSPTPSA PVPLTEPAAQ
     PGEGHTAPNS MVEAPLPETD SQPITSCSGP FSEQYQNGES EESHEQFLKA LQNAVSTFVN
     RMKSNHMRGR SITNDSAVLS LFQSINSTHP QLLELLNRLD ERRLYYEGLQ DKLAQIRDAR
     GALSALREEH REKLRRAAEE AERQRQIQLA QKLEIMRQKK QEYLEVQRQL AIQRLQEQEK
     ERQMRLEQQK QTVQMRAQMP AFPLPYAQLQ AMPTAGGVLY QPSGPTSFPG TFSPAGSVEG
     SPMHGVYMSQ PAPATGPYPS MPGTTADPSM VSAYMYPAGA PGAQAAPQAQ AGPTTNPAYS
     SYQPTPTPGY QNVASQAPQS LPAISQPPQT SNIGYMGSQP MSMGYQPYNM QNLMTTLPGQ
     DASLPAQQPY ITGQQPMYQQ MAPSTGPPQQ QPPVAQPPPT QGPPAQGNET QLISFD
//
